Kiniksa Pharmaceuticals, Ltd. (KNSA) Financials
KNSA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 519.7 million | ? |
| 2023-12-31 | 526.3 million | 87.5 million |
| 2023-09-30 | 483.1 million | 77.9 million |
| 2023-06-30 | 484.3 million | 72.7 million |
KNSA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | ? | 7.2 million |
| 2023-12-31 | 4.3 million | 7.8 million |
| 2023-09-30 | 17.0 million | 6.8 million |
| 2023-06-30 | -3.8 million | 6.5 million |
KNSA Net Income
No data available :(
KNSA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 206.4 million | - | - |
| 2023-12-31 | 206.4 million | - | 12.3 million |
| 2023-09-30 | 201.1 million | - | 13.0 million |
| 2023-06-30 | 185.0 million | - | 13.5 million |
KNSA Shares Outstanding
KNSA Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | - | 26.3 million | - | - |
| 2023-12-31 | 56000 | 19.8 million | 36.7 million | - |
| 2023-09-30 | 16000 | 17.1 million | 34.5 million | - |
| 2023-06-30 | 34000 | 23.8 million | 29.2 million | - |
KNSA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 79.9 million | 31.4 million |
| 2023-12-31 | 83.4 million | 26.8 million |
| 2023-09-30 | 67.0 million | 26.4 million |
| 2023-06-30 | 71.5 million | 21.7 million |
KNSA
Price: $17.88
52 week price:
Earnings Per Share: 0.20 USD
P/E Ratio: -183.36
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 221500
Market Capitalization: 1.2 billion